This page contains information about 9-(β-D-Ribofuranosyl)isoguanine Cas 1818-71-9 and its Metabolites.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."